TG Therapeutics reported 19.64 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
AbbVie 23.96 0.93 Jun/2026
Amgen 18.07 1.77 Jun/2026
Arrowhead Research 39.19 0 Jun/2026
Bayer 4.14 0.74 Jun/2026
Biogen 23.23 9.53 Jun/2026
Corcept Therapeutics 188.23 74.66 Jun/2026
Gilead Sciences 13.51 4.2 Jun/2026
J&J 29.43 4.9 Jun/2026
Novartis 22.41 2.24 Jun/2026
Novavax 2.01 1.07 Dec/2025
PTC Therapeutics 8.76 1.22 Mar/2026
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Roche Holding 16.48 0.39 Jun/2026
TG Therapeutics 19.64 7.65 Jun/2026
Vertex Pharmaceuticals 28.05 2.22 Jun/2026